The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Hill-Rom Holdings (NYSE:HRC) closed a $400 million acquisition of Michigan-based Aspen Surgical Products, the companies announced yesterday.
The merger bolsters Hill-Rom’s footprint in surgical devices with Aspen’s safety scalpels and blades, fluid collection products, specialty needs and other operating room disposables and instruments.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon Endo-Surgery alerted U.K. regulators after discovering counterfeit LigaClip surgical clips on the U.S. market that may have also been distributed to U.K. hospitals.
Updated: July 18, 2012 11:30 a.m.
OptiMedica Corp. is making waves and challenging the leaders in global eye care with its Catalys Precision Laser system for cataract surgery and CEO Mark Forchette isn’t shy about extolling his company’s potential.
MASSDEVICE ON CALL — Chinese teenagers exhibit rates of diabetes nearly 4 times higher than U.S. teenagers, according to a new report from University of North Carolina at Chapel Hill researchers.
The study is the longest of its kind of China, following more than 29,000 patients in 300 communities from 1989 to 2011, using data from the China Health & Nutrition Surveys.
The results, published in Obesity Reviews, suggest that 15% of Chinese children aged 7-17 have symptoms of pre-diabetes, and 2% are diabetic.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon Endo-Surgery warned healthcare providers this week that it discovered counterfeit LigaClip surgical devices in distribution in the U.S.
Early results from a long-term study of prostate cancer patients concluded that removal of the gland barely increased the likelihood for survival in patients with low-risk tumors, concluding that the surgical approach "may be neither necessary nor effective."
Johnson & Johnson (NYSE:JNJ) Ethicon Endo-Surgery won FDA clearance for the 1st surgical instruments that can be assembled and disassembled inside the body during surgery.
French health care giant Sanofi (NYSE:SNY) signed a definitive agreement to acquire hydrogel maker Pluromed for an undisclosed amount.
Sanofi plans to commercialize Woburn, Mass.-based Pluromed’s LeGoo polymer plug, an injectable gel used during surgical procedures in place of a clamp or snare.
